STAAR SURGICAL (STAA) competitors & alternatives
Health Care · NASDAQ
STAAR SURGICAL (STAA)'s top competitors and alternatives — its most similar public companies — include Johnson & Johnson (JNJ), Cooper Companies (The) (COO), LENZ THERAPEUTICS INC (LENZ), SPYGLASS PHARMA INC SHS (SGP), Aldeyra Therapeutics, Inc. (ALDX), TARSUS PHARMACEUTICALS INC (TARS), GLAUKOS CORP (GKOS), RXSIGHT INC (RXST), Abbott Laboratories (ABT), TREACE MEDICAL CONCEPTS, INC. (TMCI), UFP TECHNOLOGIES INC (UFPT) and Apyx Medical Corp (APYX). These are STAAR SURGICAL's closest public-company peers by sub-industry, sector and business themes and is informational only — not financial advice.
Top STAA competitors & alternatives
-
Johnson & JohnsonJNJHealth Care
A global healthcare leader spanning pharmaceuticals, medical devices, and consumer health products, with a portfolio spanning acute care, oncology, immunology,…
$255.63 (as of 2026-07-22) · market cap $614.6B
-
Cooper Companies (The)COOHealth Care
A global medical device leader operating at the intersection of vision care and women's health through its CooperVision and CooperSurgical divisions.
$70.50 (as of 2026-07-22) · market cap $13.9B
-
LENZ THERAPEUTICS INCLENZHealth Care
LENZ Therapeutics is a commercial-stage ophthalmic company that developed VIZZ, the first FDA-approved, once-daily aceclidine-based eye drop for the treatment…
$5.34 (as of 2026-07-22) · market cap $167M
-
SPYGLASS PHARMA INC SHSSGPHealth Care
Spyglass Pharma is a clinical-stage biotech developing an innovative sustained-release drug delivery platform to improve patient outcomes in cataract surgery.
$20.54 (as of 2026-07-22) · market cap $682M
-
Aldeyra Therapeutics, Inc.ALDXHealth Care
Aldeyra is a clinical-stage biotech pursuing FDA approval of reproxalap, an aldehyde dehydrogenase activator for ophthalmologic inflammation, dependent on…
$1.70 (as of 2026-07-22) · market cap $106M
-
TARSUS PHARMACEUTICALS INCTARSHealth Care
Tarsus Pharmaceuticals commercializes XDEMVY, the first FDA-approved treatment for Demodex blepharitis, with a pipeline of lotilaner-based therapies for ocular…
$57.58 (as of 2026-07-22) · market cap $2.5B
-
GLAUKOS CORPGKOSHealth Care
Glaukos is a specialized ophthalmic company transforming eye care through innovative Micro-Invasive Glaucoma Surgery devices and proprietary sustained-release…
$152.86 (as of 2026-07-22) · market cap $8.9B
-
RXSIGHT INCRXSTHealth Care
RxSight is the only company commercializing light-adjustable intraocular lenses that let surgeons customize patient vision after cataract surgery, eliminating…
$5.39 (as of 2026-07-22) · market cap $223M
-
Abbott LaboratoriesABTHealth Care
Abbott Laboratories is a diversified healthcare giant providing a broad portfolio of diagnostic systems, medical devices, nutritional products, and established…
$100.57 (as of 2026-07-22) · market cap $175.1B
-
TREACE MEDICAL CONCEPTS, INC.TMCIHealth Care
Treace is a focused orthopedic medical device company specializing in innovative 3D bunion correction and foot surgery systems for hospitals and surgical…
$3.97 (as of 2026-07-22) · market cap $258M
-
UFP TECHNOLOGIES INCUFPTHealth Care
A specialized contract manufacturer producing custom single-use and single-patient medical devices for major OEMs across minimally invasive surgery, wound…
$237.96 (as of 2026-07-22) · market cap $1.9B
-
Apyx Medical CorpAPYXHealth Care
Apyx Medical provides advanced helium plasma-based surgical technology for cosmetic body contouring and hospital-based electrosurgical procedures.
$3.91 (as of 2026-07-22) · market cap $163M
Not quite? Describe exactly what you want →
Peers are STAAR SURGICAL's closest public companies by shared sub-industry, sector and business themes. See the full profile: STAAR SURGICAL (STAA).
Last updated 2026-07-22.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.